Acrivon Therapeutics (ACRV) Financials: Revenue & Earnings

ACRV price $1.75 +0.01 +0.57%

Ticker
ACRV
Price
$1.75
Change
+0.01 +0.57%
Market cap ?
$74.99M
P/E ?
-0.93
Dividend yield ?
0.00%
Beta ?
1.93
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
69
Value
57
Quality
50
Growth
100

Stocklytics score rationale: value 57, quality 50, growth 100.

Financials

202020212022202320242025
000000

Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves…

Fair value

ACRV fair value Not meaningful. Price $1.75.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ACRV

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.45—504.33K
2026-08-12-0.43-0.50—386.33K
2026-05-13-0.49-0.49—277.17K
2026-03-19-0.49-0.49—166.29K
2025-11-13-0.47-0.57——
2025-08-13-0.55-0.57——
2025-05-14-0.51-0.57——
2025-03-27-0.60-0.69——
2024-11-13-0.59-0.56——
2024-08-13-0.52-0.59——
2024-05-14-0.73-0.89——
2024-03-28-0.86-0.721.88M—
2023-11-09-0.66-0.72——
2023-08-11-0.63-0.68——
2023-05-09-0.58-0.60——
2023-03-28-0.80-1.09——
2022-12-15-5.17-2.44——
2022-08-14-0.44———
2022-05-15-0.56———
2022-02-14-0.17———
2021-12-31-0.34———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-22Miller MarySell513$1.84944
2026-10-05Miller MarySell294$1.99585
2026-08-31Levin MichaelaBuy130.00K$2.09271.70K
2026-08-31Levin MichaelaBuy30.00K——
2026-08-31Levin MichaelaOther0——
2026-08-25Blume-Jensen PeterSell14.04K$2.2130.97K
2026-08-18Peterson KatharineSell101$2.01203
2026-08-18Miller MarySell185$2.01372
2026-08-18Gamelin ErickSell400$2.01804
2026-08-18Devroe EricSell604$2.011.21K
2026-08-18Blume-Jensen PeterSell1.23K$2.012.47K
2026-08-18Blume-Jensen PeterSell484$2.01973
2026-08-04Levy Adam D.Sell1.14K$1.571.79K
2026-07-21Miller MarySell573$1.761.01K
2026-06-17RA CAPITAL MANAGEMENT, L.P.Buy20.27K$1.5230.82K
2026-06-17TOMSICEK MICHAEL JOHNBuy20.27K$1.5230.82K
2026-06-17Shacham SharonBuy20.27K$1.5230.82K
2026-06-17Palani SanthoshBuy20.27K$1.5230.82K
2026-06-17Magovcevic-Liebisch IvanaBuy20.27K$1.5230.82K
2026-06-17DiRocco DerekBuy20.27K$1.5230.82K
2026-06-17BAUM CHARLES MBuy20.27K$1.5230.82K
2026-05-21Blume-Jensen PeterSell13.73K$1.7924.57K
2026-05-18RA CAPITAL MANAGEMENT, L.P.Buy9.37K——
2026-05-18TOMSICEK MICHAEL JOHNBuy9.37K——
2026-05-18Shacham SharonBuy9.37K——
2026-05-18Palani SanthoshBuy9.37K——
2026-05-18Magovcevic-Liebisch IvanaBuy9.37K——
2026-05-18DiRocco DerekBuy9.37K——
2026-05-18BAUM CHARLES MBuy9.37K——
2026-05-18Peterson KatharineBuy14.23K——
2026-05-18Mirza Mansoor RazaBuy38.82K——
2026-05-18Miller MaryBuy49.83K——
2026-05-18Levy Adam D.Buy46.17K——
2026-05-18Gamelin ErickBuy38.58K——
2026-05-18Devroe EricBuy72.98K——
2026-05-18Blume-Jensen PeterBuy180.09K——
2026-05-18Blume-Jensen PeterBuy72.71K——
2026-05-14Peterson KatharineSell99$1.92190
2026-05-14Miller MarySell184$1.92353
2026-05-14Gamelin ErickSell404$1.92776
2026-05-14Devroe EricSell613$1.921.18K
2026-05-14Blume-Jensen PeterSell1.25K$1.922.41K
2026-05-14Blume-Jensen PeterSell490$1.92941
2026-04-22RA CAPITAL MANAGEMENT, L.P.Buy3.89M$1.807.00M
2026-04-17Miller MarySell558$1.78993
2026-03-01Peterson KatharineBuy31.90K$1.5148.17K
2026-03-01Mirza Mansoor RazaBuy174.07K$1.51262.84K
2026-03-01Miller MaryBuy129.76K$1.51195.94K
2026-03-01Levy Adam D.Buy132.93K$1.51200.72K
2026-03-01Gamelin ErickBuy94.95K$1.51143.37K
2026-03-01Devroe EricBuy186.73K$1.51281.96K
2026-03-01Blume-Jensen PeterBuy417.21K$1.51629.99K
2026-03-01Blume-Jensen PeterBuy185.50K$1.51280.10K
2026-02-21Blume-Jensen PeterSell14.27K$1.5321.83K
2026-02-14Peterson KatharineSell116$1.63189
2026-02-14Miller MarySell217$1.63354
2026-02-14Gamelin ErickSell471$1.63768
2026-02-14Devroe EricSell723$1.631.18K
2026-02-14Blume-Jensen PeterSell1.30K$1.632.12K
2026-02-14Blume-Jensen PeterSell579$1.63944
2026-01-17Miller MarySell659$1.981.30K
2026-01-14Blume-Jensen PeterBuy49.00K$1.6882.12K
2026-01-14Levy Adam D.Buy8.83K$1.7015.00K
2026-01-13Devroe EricBuy10.00K$1.7217.22K
2025-11-21Blume-Jensen PeterSell19.90K$2.3045.78K
2025-11-14Peterson KatharineSell99$2.24222
2025-11-14Miller MarySell184$2.24412
2025-11-14Gamelin ErickSell403$2.24903
2025-11-14Devroe EricSell613$2.241.37K
2025-11-14Blume-Jensen PeterSell59.77K$2.24133.87K
2025-11-14Blume-Jensen PeterSell490$2.241.10K
2025-10-17Miller MarySell558$1.811.01K
2025-10-01Mirza Mansoor RazaBuy225.00K$1.81407.25K
2025-10-01Miller MarySell284$1.81514
2025-08-21Blume-Jensen PeterSell19.91K$1.3226.27K
2025-08-14Peterson KatharineSell99$1.39138
2025-08-14Miller MarySell184$1.39256
2025-08-14Gamelin ErickSell403$1.39560
2025-08-14Devroe EricSell613$1.39852
2025-08-14Blume-Jensen PeterSell59.77K$1.3983.07K
2025-08-14Blume-Jensen PeterSell490$1.39681
2025-08-01Levy Adam D.Sell1.16K$1.261.47K
2025-07-17Miller MarySell558$1.32737
2025-06-13RA CAPITAL MANAGEMENT, L.P.Buy20.27K$1.2024.33K
2025-06-13DiRocco DerekBuy20.27K$1.2024.33K
2025-06-13TOMSICEK MICHAEL JOHNBuy20.27K$1.2024.33K
2025-06-13Shacham SharonBuy20.27K$1.2024.33K
2025-06-13Palani SanthoshBuy20.27K$1.2024.33K
2025-06-13Magovcevic-Liebisch IvanaBuy20.27K$1.2024.33K
2025-06-13BAUM CHARLES MBuy20.27K$1.2024.33K
2025-05-21Blume-Jensen PeterSell19.90K$1.1522.89K
2025-05-14Peterson KatharineSell99$1.14113
2025-05-14Miller MarySell184$1.14210
2025-05-14Gamelin ErickSell403$1.14459
2025-05-14Devroe EricSell613$1.14699
2025-05-14Blume-Jensen PeterSell59.77K$1.1468.13K
2025-05-14Blume-Jensen PeterSell491$1.14560
2025-05-01PERCEPTIVE ADVISORS LLCSell298.89K$1.34400.51K
2025-04-30PERCEPTIVE ADVISORS LLCSell437.88K$1.41617.41K
2025-04-29PERCEPTIVE ADVISORS LLCSell250.00K$1.41352.50K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 45, holders +2 vs prior quarter. Ownership 51.15%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.12.23M3.89M+46.63%21.77M
SANDS CAPITAL ALTERNATIVES, LLC2.29M166.67K+7.85%4.07M
ACADIAN ASSET MANAGEMENT LLC1.17M319.15K+37.73%2.07M
VANGUARD CAPITAL MANAGEMENT LLC952.01K229.97K+31.85%1.69M
WELLINGTON MANAGEMENT GROUP LLP888.13K00.00%1.58M
RENAISSANCE TECHNOLOGIES LLC758.86K423+0.06%1.35M
TWO SIGMA INVESTMENTS, LP641.50K252.10K+64.74%1.14M
MARSHALL WACE, LLP531.86K-28.58K-5.10%946.70K
BRIDGEWAY CAPITAL MANAGEMENT, LLC378.90K220.00K+138.45%674.44K
GEODE CAPITAL MANAGEMENT, LLC265.24K28.85K+12.20%472.27K
BLACKROCK, INC.239.11K30.17K+14.44%425.62K
GSA CAPITAL PARTNERS LLP200.41K13.70K+7.34%357.00K
VANGUARD FIDUCIARY TRUST CO184.13K76.60K+71.24%327.75K
XTX TOPCO LTD178.24K111.36K+166.50%317.26K
JANE STREET GROUP, LLC74.65K-165.04K-68.86%132.87K
NORTHERN TRUST CORP67.20K18.30K+37.42%119.62K
STATE STREET CORP67.14K00.00%119.52K
UBS GROUP AG43.85K9.22K+26.61%78.05K
CITADEL ADVISORS LLC41.28K41.28KNew73.47K
DIMENSIONAL FUND ADVISORS LP29.33K10.97K+59.73%52.21K
SPARK INVESTMENT MANAGEMENT LLC28.30K28.30KNew50.37K
PRELUDE CAPITAL MANAGEMENT, LLC24.02K00.00%42.75K
BANK OF AMERICA CORP /DE/16.41K-106-0.64%29.20K
VERDAD ADVISERS, LP15.05K15.05KNew26.80K
GOLDMAN SACHS GROUP INC14.92K178+1.21%26.56K

Earnings and financials

Acrivon Therapeutics, Inc. Common Stock (ACRV) trades at $1.75, with a market cap of $74.99M and a trailing P/E of -0.93. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

202020212022202320242025
000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Acrivon Therapeutics (ACRV) Financials: Revenue & Earnings

ACRV$1.75+0.01 +0.57%

$74.99M

Market Cap

-0.93

P/E

—

Forward P/E

69

Score

Price History